Steffani R Bailey, Jean P O'Malley, Daniel M Hartung, Nathalie Huguet, Miguel Marino, John Muench
{"title":"社区卫生中心慢性疼痛患者镇痛药美沙酮处方。","authors":"Steffani R Bailey, Jean P O'Malley, Daniel M Hartung, Nathalie Huguet, Miguel Marino, John Muench","doi":"10.5055/jom.0811","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To examine analgesic methadone prescriptions among community health center (CHC) patients with chronic pain.</p><p><strong>Design: </strong>Observational; two cross-sectional periods.</p><p><strong>Setting: </strong>Oregon and California CHCs.</p><p><strong>Patients: </strong>Chronic pain patients with ≥1 visit in 2012-2013 or 2017-2018 (N = 158,239).</p><p><strong>Outcomes: </strong>Changes in adjusted relative rates (aRRs) of receiving no opioids, short-acting only, long-acting only other than methadone, and methadone; characteristics associated with ≥1 methadone prescription.</p><p><strong>Results: </strong>Opioid prescribing declined over time, with the largest decrease in methadone (aRR = 0.19, 95 percent confidence interval: 0.14-0.27). Among patients receiving ≥1 long-acting opioid, variables associated with methadone prescribing included being aged <65 years, having nonprivate insurance, and an opioid use disorder (OUD) diagnosis. From 2012-2013 to 2017-2018, aRR increased among patients with OUD and decreased for those aged 18-30 (vs ≥65), uninsured and Medicaid-insured (vs private), and race/ethnicity other than non-Hispanic Black (vs non-Hispanic White).</p><p><strong>Conclusions: </strong>Methadone prescribing decreased in CHCs but remained elevated for several high-risk demographic groups.</p>","PeriodicalId":16601,"journal":{"name":"Journal of opioid management","volume":"19 5","pages":"369-375"},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11423870/pdf/","citationCount":"0","resultStr":"{\"title\":\"Analgesic methadone prescribing in community health centers among patients with chronic pain.\",\"authors\":\"Steffani R Bailey, Jean P O'Malley, Daniel M Hartung, Nathalie Huguet, Miguel Marino, John Muench\",\"doi\":\"10.5055/jom.0811\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>To examine analgesic methadone prescriptions among community health center (CHC) patients with chronic pain.</p><p><strong>Design: </strong>Observational; two cross-sectional periods.</p><p><strong>Setting: </strong>Oregon and California CHCs.</p><p><strong>Patients: </strong>Chronic pain patients with ≥1 visit in 2012-2013 or 2017-2018 (N = 158,239).</p><p><strong>Outcomes: </strong>Changes in adjusted relative rates (aRRs) of receiving no opioids, short-acting only, long-acting only other than methadone, and methadone; characteristics associated with ≥1 methadone prescription.</p><p><strong>Results: </strong>Opioid prescribing declined over time, with the largest decrease in methadone (aRR = 0.19, 95 percent confidence interval: 0.14-0.27). Among patients receiving ≥1 long-acting opioid, variables associated with methadone prescribing included being aged <65 years, having nonprivate insurance, and an opioid use disorder (OUD) diagnosis. From 2012-2013 to 2017-2018, aRR increased among patients with OUD and decreased for those aged 18-30 (vs ≥65), uninsured and Medicaid-insured (vs private), and race/ethnicity other than non-Hispanic Black (vs non-Hispanic White).</p><p><strong>Conclusions: </strong>Methadone prescribing decreased in CHCs but remained elevated for several high-risk demographic groups.</p>\",\"PeriodicalId\":16601,\"journal\":{\"name\":\"Journal of opioid management\",\"volume\":\"19 5\",\"pages\":\"369-375\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11423870/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of opioid management\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5055/jom.0811\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of opioid management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5055/jom.0811","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Analgesic methadone prescribing in community health centers among patients with chronic pain.
Objective: To examine analgesic methadone prescriptions among community health center (CHC) patients with chronic pain.
Design: Observational; two cross-sectional periods.
Setting: Oregon and California CHCs.
Patients: Chronic pain patients with ≥1 visit in 2012-2013 or 2017-2018 (N = 158,239).
Outcomes: Changes in adjusted relative rates (aRRs) of receiving no opioids, short-acting only, long-acting only other than methadone, and methadone; characteristics associated with ≥1 methadone prescription.
Results: Opioid prescribing declined over time, with the largest decrease in methadone (aRR = 0.19, 95 percent confidence interval: 0.14-0.27). Among patients receiving ≥1 long-acting opioid, variables associated with methadone prescribing included being aged <65 years, having nonprivate insurance, and an opioid use disorder (OUD) diagnosis. From 2012-2013 to 2017-2018, aRR increased among patients with OUD and decreased for those aged 18-30 (vs ≥65), uninsured and Medicaid-insured (vs private), and race/ethnicity other than non-Hispanic Black (vs non-Hispanic White).
Conclusions: Methadone prescribing decreased in CHCs but remained elevated for several high-risk demographic groups.
期刊介绍：
The Journal of Opioid Management deals with all aspects of opioids. From basic science, pre-clinical, clinical, abuse, compliance and addiction medicine, the journal provides and unbiased forum for researchers and clinicians to explore and manage the complexities of opioid prescription.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
